GCP
ONC

GSA Capital Partners’s BeOne Medicines Ltd ONC Stock Holding History

GSA Capital Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
4,734
+1,404
+42% +$414K 0.09% 334
2026
Q1 		$989K Buy
+3,330
New +$1.08M 0.06% 502
2025
Q4 		– Sell
-3,223
Closed -$1.1M – 2173
2025
Q3 		$1.1M Sell
3,223
-86
-3% -$26.1K 0.09% 348
2025
Q2 		$801K Buy
3,309
+150
+5% +$36.8K 0.06% 605
2025
Q1 		$860K Buy
+3,159
New +$739K 0.08% 441
2023
Q3 		– Sell
-1,177
Closed -$210K – 1986
2023
Q2 		$210K Buy
+1,177
New +$271K 0.02% 1238
2021
Q4 		– Sell
-1,560
Closed -$566K – 1860
2021
Q3 		$566K Buy
+1,560
New +$510K 0.06% 631

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GSA Capital Partners's ONC Position: Q2 2026 in Review

GSA Capital Partners increased its BeOne Medicines Ltd (ONC) stake by 42% in Q2 2026, buying an estimated $414K and bringing the position to 4,734 shares worth $1.35M. The position accounts for 0.09% of the portfolio, ranked #334.

GSA Capital Partners first reported a position in ONC in Q3 2021 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • GSA Capital Partners held 4,734 shares of BeOne Medicines Ltd worth $1.35M as of Q2 2026.
  • GSA Capital Partners bought 1,404 BeOne Medicines Ltd shares in Q2 2026, an estimated $414K.
  • BeOne Medicines Ltd made up 0.09% of GSA Capital Partners's portfolio in Q2 2026, its #334 holding.
  • GSA Capital Partners first reported a position in BeOne Medicines Ltd in Q3 2021 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.